Systemic Host Responses in Severe Sepsis Analyzed by Causative Microorganism and Treatment Effects of Drotrecogin Alfa (Activated)
Open Access
- 1 July 2003
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (1) , 50-58
- https://doi.org/10.1086/375593
Abstract
Clinical trials with novel therapeutic agents for severe sepsis have suggested that patients might respond differently depending on causative microorKeywords
This publication has 35 references indexed in Scilit:
- Epidemiology of sepsis: An updateCritical Care Medicine, 2001
- Clinical Gram-positive sepsisCritical Care Medicine, 1999
- Derangements of Coagulation and Fibrinolysis in Critically III Patients with Sepsis and Septic ShockSeminars in Thrombosis and Hemostasis, 1998
- Role of the Coagulation System in the Local and Systemic Inflammatory ResponseWorld Journal of Surgery, 1998
- Anti-inflammatory therapies to treat sepsis and septic shockCritical Care Medicine, 1997
- Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion ProteinNew England Journal of Medicine, 1996
- Hemodynamic responses to Gram-positive versus Gram-negative sepsis in critically ill patients with and without circulatory shockCritical Care Medicine, 1991
- Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock.Journal of Clinical Investigation, 1989
- The systemic septic responseCritical Care Medicine, 1980
- Changes in the Blood Coagulation System Associated with SepticemiaNew England Journal of Medicine, 1968